The company will not receive any proceeds from the sale of the shares by the selling stockholders. Invest with Confidence: Follow TipRanks' Top ...

Vor Biopharma Inc. (NYSE:VOR – Get Free Report) has received an average rating of “Buy” from the seven analysts that are ...

Vor Bio expects to use net proceeds from the PIPE to fund clinical and preclinical development of its pipeline candidates and for general corporate purposes. Vor Bio expects to announce updated ...

Vor announced it entered into a securities purchase agreement for a private investment in public equity financing. The company expects to generate about $55.6 million in gross proceeds.

https://www.tipranks.com/news/the-fly/kazia-therapeutics-to-sell-1-33m-ads-at-1-50-in-registered-direct-offering The latest announcement is out from Vor Biopharma ...

A Buddha Air flight with 76 people on board made an emergency VOR landing at Tribhuvan International Airport in Kathmandu after experiencing a flame-out in its left engine.

Friday's private investment in public equity transaction valued at $55.6 million by Vor Biopharma Inc. (VOR, Financials) sent its stock price skyrocketing 46.78% to finish at $1.23. The funding is ...

Vor Bio (VOR) announced the appointment of Erez Kalir to its Board of Directors. The appointment represents a new seat on Vor Bio’s Board of ...

Vor Bio, a clinical-stage cell and genome engineering company, has appointed Mr. Erez Kalir to its Board of Directors, creating a new seat following a recent private investment in public equity ...

Vor shares are higher lower on Friday after the company announced it has entered into a securities purchase agreement for a private investment in public equity financing. Vor Biopharma reveals ...